These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 16961531)
41. Toxic epidermal necrolysis in a child. A case report and review of the literature. Chiossi M; Piccotti E; Tubino B; Nemelka O; Di Pietro P Pediatr Med Chir; 2007; 29(4):218-20. PubMed ID: 17715606 [TBL] [Abstract][Full Text] [Related]
42. Etanercept for toxic epidermal necrolysis. Famularo G; Di Dona B; Canzona F; Girardelli CR; Cruciani G Ann Pharmacother; 2007 Jun; 41(6):1083-4. PubMed ID: 17456541 [No Abstract] [Full Text] [Related]
43. Accurate debridement of toxic epidermal necrolysis using Versajet. Dillon CK; Lloyd MS; Dzeiwulski P Burns; 2010 Jun; 36(4):581-4. PubMed ID: 19423228 [No Abstract] [Full Text] [Related]
44. [The disease picture of acute toxic epidermolsis in children caused by drug intolerance. Report on 4 personal cases]. Sitzmann FC; Kasper W; Schuch P Z Kinderheilkd; 1967; 100(2):101-12. PubMed ID: 4298391 [No Abstract] [Full Text] [Related]
45. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis. Stella M; Clemente A; Bollero D; Risso D; Dalmasso P Burns; 2007 Jun; 33(4):452-9. PubMed ID: 17475410 [TBL] [Abstract][Full Text] [Related]
46. Etanercept in the treatment of a patient with acute generalized exanthematous pustulosis/toxic epidermal necrolysis: definition of a new model based on translational research. Sadighha A Int J Dermatol; 2009 Aug; 48(8):913-4. PubMed ID: 19659879 [No Abstract] [Full Text] [Related]
47. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825 [TBL] [Abstract][Full Text] [Related]
48. Toxic epidermal necrolysis. A case report. Bintliff SJ Hawaii Med J; 1966; 25(6):468-9. PubMed ID: 5941109 [No Abstract] [Full Text] [Related]
54. The use of intravenous immunoglobulin for treatment of dermatological conditions in Australia: A review. Smith SD; Dennington PM; Cooper A Australas J Dermatol; 2010 Nov; 51(4):227-37. PubMed ID: 21198517 [TBL] [Abstract][Full Text] [Related]
55. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Koh MJ; Tay YK Curr Opin Pediatr; 2009 Aug; 21(4):505-10. PubMed ID: 19474732 [TBL] [Abstract][Full Text] [Related]
58. Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis. Wojtkiewicz A; Wysocki M; Fortuna J; Chrupek M; Matczuk M; Koltan A Acta Derm Venereol; 2008; 88(4):420-1. PubMed ID: 18709327 [No Abstract] [Full Text] [Related]
59. Toxic epidermal necrolysis and Steven Johnson syndrome: 11-years experience and outcome. Gravante G; Delogu D; Marianetti M; Trombetta M; Esposito G; Montone A Eur Rev Med Pharmacol Sci; 2007; 11(2):119-27. PubMed ID: 17552141 [TBL] [Abstract][Full Text] [Related]